Expression of (ZO-1 & PLVAP) Antibody in the Sulcus Medianus Organum of Rat
DOI:
https://doi.org/10.61841/yxa4z940Keywords:
Circumventricular Organs(CVO), Sulcus Medianus Organum (SMO), Median Eminence (ME), ZO- 1 Antibody (Zonula Occludens-1 Antibody), PLVAP Antibody (Plasmalema Vesicle Associated Antibody), TanycytesAbstract
The circumventricular organs (CVOs) are peculiar structures that border the brain ventricles; they are highly vascularized and lined by specialized ependymal cells called tanycytes. There are seven CVOs that are generally characterized by a deficient blood-brain barrier and can be classified into two main groups (sensory and secretory CVOs). The sulcus medianus organum (SMO) is a previously described CVO located at the floor of the fourth ventricle at the rostral part of the median sulcus; little information is available about this region of the brain. This research performed an immunohistochemical study considering the capillaries and the ependymal lining of this region to explore observations suggesting this region as a CVO. Twenty adult male rats (Rattus Norvegius Albinus)
Aged 3-6 months were used to study the immunohistochemistry of the SMO & the median eminence (ME), which was used as a control region since it is a well-known CVO lined by specialized ependymal cells (tanycytes) and richly vascularized with fenestrated capillaries. The immunohistochemical study involved the use of the ZO-1 antibody to detect the tight junctions and the PLVAP antibody to explore the presence of fenestrated capillaries. The immunohistochemical labeling findings showed a ZO-1 antibody reactivity that forms a continuous green line at the apical aspects of the ependymal lining of both SMO & ME. The PLVAP antibody labeling showed a negative reactivity at the region of the SMO in comparison to the ME, which showed a positive reactivity. Conclusively, the SMO region contains ependymal lining cells that could be regarded as tanycyte-like cells, and the blood vessels in this region showed features indicating the presence of a blood-brain barrier. However, the presence of fenestrated capillaries cannot be excluded totally, and the use of vascular permeability study or electron microscopy to explore the ultra-structural properties of the ependymal lining and the blood vessels at that region was recommended.
Downloads
References
[1] Ahmed, F. H., Al-Kaabi, M. A., Al-Marsoummi, S. E., & Al-Aubaidy, H. A. (2017). Localization of tight
junctions between tanycyte-like cells of the sulcus medianus organum in the rat brain. Iraqi Journal of
Medical Sciences, 15(1), 48-63.
[2] Bancroft, J. D., & Gamble, M. (Eds.). (2008). Theory and practice of histological techniques. Elsevier
health sciences.
[3] Carson-Walter, E. B., Hampton, J., Shue, E., Geynisman, D. M., Pillai, P. K., Sathanoori, R., ... & Walter,
K. A. (2005). Plasmalemmal vesicle associated protein-1 is a novel marker implicated in brain tumor
Angiogenesis. Clinical cancer research, 11(21), 7643-7650.
[4] Collins, P. A. T. R. I. C. I. A. (1989). The sulcus medianus organ in the fourth cerebral ventricle of the
rabbit: a previously undescribed circumventricular organ. Journal of anatomy, 162, 185.
[5] Deharvengt, S. J., Tse, D., Sideleva, O., McGarry, C., Gunn, J. R., Longnecker, D. S., ... & Stan, R. V.
(2012). PV1 down-regulation via shRNA inhibits the growth of pancreatic adenocarcinoma
Xenografts. Journal of cellular and molecular medicine, 16(11), 2690-2700.
[6] Duvernoy, H. M., & Risold, P. Y. (2007). The circumventricular organs: an atlas of comparative anatomy
and vascularization. Brain research reviews, 56(1), 119-147.
[7] Hallmann, R., Mayer, D. N., Berg, E. L., Broermann, R., & Butcher, E. C. (1995). Novel mouse endothelial
Cell surface marker is suppressed during differentiation of the blood-brain barrier. Developmental
dynamics, 202(4), 325-332.
[8] Joly, J. S., Osório, J., Alunni, A., Auger, H., Kano, S., & Rétaux, S. (2007, August). Windows of the brain:
towards a developmental biology of circumventricular and other neurohemal organs. In Seminars in cell &
developmental biology (Vol. 18, No. 4, pp. 512-524). Academic Press.
[9] Kaur, C., & Ling, E. A. (2017). The circumventricular organs. Histology and histopathology, 32(9), 879-892.
[10] Paxinos, G. (Ed.). (2014). The rat nervous system. Academic Press.
[11] Petrov, T., Howarth, A. G., Krukoff, T. L., & Stevenson, B. R. (1994). Distribution of the tight junction-associated protein ZO-1 in circumventricular organs of the CNS. Molecular brain research, 21(3-4), 235-246.
[12] Ruberte, J., Carretero, A., & Navarro, M. (2017). Morphological Mouse Phenotyping: Anatomy, Histology, and Imaging. Elsevier.
[13] Saunders, N. R., Dziegielewska, K. M., Møllgård, K., & Habgood, M. D. (2018). Physiology and molecular
biology of barrier mechanisms in the fetal and neonatal brain. The Journal of physiology, 596(23), 5723-
5756.
[14] Saunders, N. R., Ek, C. J., Habgood, M. D., & Dziegielewska, K. M. (2008). Barriers in the brain: a
renaissance?. Trends in neurosciences, 31(6), 279-286.
[15] Shue, E. H., Carson-Walter, E. B., Liu, Y., Winans, B. N., Ali, Z. S., Chen, J., & Walter, K. A. (2008).
Plasmalemmal vesicle associated protein-1 (PV-1) is a marker of blood-brain barrier disruption in rodent
models. BMC neuroscience, 9(1), 29.
[16] Stan, R. V. (2005). Structure of caveolae. Biochimica et Biophysica Acta (BBA)-Molecular Cell
Research, 1746(3), 334-348.
[17] Stan, R. V., Ghitescu, L., Jacobson, B. S., & Palade, G. E. (1999). Isolation, cloning, and localization of rat
PV-1, a novel endothelial caveolar protein. The Journal of cell biology, 145(6), 1189-1198.
[18] Tse, D., & Stan, R. V. (2010, April). Morphological heterogeneity of endothelium. In Seminars in
thrombosis and hemostasis (Vol. 36, No. 03, pp. 236-245). © Thieme Medical Publishers.
[19] Umans, R. A., Henson, H. E., Mu, F., Parupalli, C., Ju, B., Peters, J. L., ... & Taylor, M. R. (2017). CNS
angiogenesis and barriergenesis occur simultaneously. Developmental biology, 425(2), 101-108.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 AUTHOR
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
